Obstacles Impeding the Development of Nanocarriers for Anticancer Drugs
Lingshan Liu,Hongjing Dou
DOI: https://doi.org/10.2217/nnm-2021-0101
2021-01-01
Nanomedicine
Abstract:NanomedicineVol. 16, No. 17 EditorialObstacles impeding the development of nanocarriers for anticancer drugsLingshan Liu & Hongjing DouLingshan Liu https://orcid.org/0000-0002-0176-1464The State Key Laboratory of Metal Matrix Composites, School of Materials Science & Engineering, Shanghai Jiao Tong University, Shanghai 200240, PR ChinaSearch for more papers by this author & Hongjing Dou *Author for correspondence: E-mail Address: hjdou@sjtu.edu.cnhttps://orcid.org/0000-0001-5850-9174The State Key Laboratory of Metal Matrix Composites, School of Materials Science & Engineering, Shanghai Jiao Tong University, Shanghai 200240, PR ChinaSearch for more papers by this authorPublished Online:18 Jun 2021https://doi.org/10.2217/nnm-2021-0101AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: endocytosismononuclear phagocytic systemnanomedicineprotein coronatumor penetrationReferences1. Sung H, Ferlay J, Siegel RL et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. doi:10.3322/caac.21660 (2021) (Epub ahead of print).Crossref, Medline, Google Scholar2. Miller KD, Nogueira L, Mariotto AB et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J. Clin. 69(5), 363–385 (2019).Crossref, Medline, Google Scholar3. Youn YS, Bae YH. Perspectives on the past, present, and future of cancer nanomedicine. Adv. Drug Deliv. Rev. 130, 3–11 (2018).Crossref, Medline, CAS, Google Scholar4. Sun T, Zhang YS, Pang B, Hyun DC, Yang M, Xia Y. Engineered nanoparticles for drug delivery in cancer therapy. Angew. Chem. Int. Ed. Engl. 53(46), 12320–12364 (2014).Medline, CAS, Google Scholar5. Xing R, Liu K, Jiao T et al. An injectable self-assembling collagen-gold hybrid hydrogel for combinatorial antitumor photothermal/photodynamic therapy. Adv. Mater. 28(19), 3669–3676 (2016).Crossref, Medline, CAS, Google Scholar6. Liu Y, Bhattarai P, Dai Z, Chen X. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem. Soc. Rev. 48(7), 2053–2108 (2019).Crossref, Medline, CAS, Google Scholar7. Karimi M, Ghasemi A, Sahandi Zangabad P et al. Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chem. Soc. Rev. 45(5), 1457–1501 (2016).Crossref, Medline, CAS, Google Scholar8. Fan W, Yung B, Huang P, Chen X. Nanotechnology for multimodal synergistic cancer therapy. Chem. Rev. 117(22), 13566–13638 (2017).Crossref, Medline, CAS, Google Scholar9. Wilhelm S, Tavares A, Dai QEA. Analysis of nanoparticle delivery to tumors. Nat. Rev. Mater. 1(5), 16014 (2016).Crossref, CAS, Google Scholar10. Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat. Rev. Cancer 17(1), 20–37 (2017).Crossref, Medline, CAS, Google Scholar11. Khawar IA, Kim JH, Kuh HJ. Improving drug delivery to solid tumors: priming the tumor microenvironment. J. Control. Release 201, 78–89 (2015).Crossref, Medline, CAS, Google Scholar12. Maeda H, Nakamura H, Fang J. The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv. Drug Deliv. Rev. 65(1), 71–79 (2013).Crossref, Medline, CAS, Google Scholar13. Nicolas J, Mura S, Brambilla D, Mackiewicz N, Couvreur P. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem. Soc. Rev. 42(3), 1147–1235 (2013).Crossref, Medline, CAS, Google Scholar14. Lv Y, Xu C, Zhao X et al. Nanoplatform assembled from a CD44-targeted prodrug and smart liposomes for dual targeting of tumor microenvironment and cancer cells. ACS Nano 12(2), 1519–1536 (2018).Crossref, Medline, CAS, Google Scholar15. Cai R, Chen C. The crown and the scepter: roles of the protein corona in nanomedicine. Adv. Mater. 31(45), 1805740 (2019).Crossref, CAS, Google Scholar16. Rosenblum D, Joshi N, Tao W, Karp JM, Peer D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat. Commun. 9(1), 1410 (2018).Crossref, Medline, Google Scholar17. Owens DE 3rd, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307(1), 93–102 (2006).Crossref, Medline, CAS, Google Scholar18. Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33(9), 941–951 (2015).Crossref, Medline, CAS, Google Scholar19. Zou Y, Ito S, Yoshino F, Suzuki Y, Zhao L, Komatsu N. Polyglycerol grafting shields nanoparticles from protein corona formation to avoid macrophage uptake. ACS Nano 14(6), 7216–7226 (2020).Crossref, Medline, CAS, Google Scholar20. Rudnick SI, Lou J, Shaller CC et al. Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors. Cancer Res. 71(6), 2250–2259 (2011).Crossref, Medline, CAS, Google Scholar21. Chauhan VP, Stylianopoulos T, Martin JD et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat. Nanotechnol. 7(6), 383–388 (2012).Crossref, Medline, CAS, Google Scholar22. Donahue ND, Acar H, Wilhelm S. Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine. Adv. Drug Deliv. Rev. 143, 68–96 (2019).Crossref, Medline, CAS, Google Scholar23. Kinnear C, Moore TL, Rodriguez-Lorenzo L, Rothen-Rutishauser B, Petri-Fink A. Form follows function: nanoparticle shape and its implications for nanomedicine. Chem. Rev. 117(17), 11476–11521 (2017).Crossref, Medline, CAS, Google Scholar24. Behzadi S, Serpooshan V, Tao W et al. Cellular uptake of nanoparticles: journey inside the cell. Chem. Soc. Rev. 46(14), 4218–4244 (2017).Crossref, Medline, CAS, Google Scholar25. Kirpotin DB, Drummond DC, Shao Y et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res. 66(13), 6732–6740 (2006).Crossref, Medline, CAS, Google Scholar26. Hühn D, Kantner K, Geidel C et al. Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge. ACS Nano 7(4), 3253–3263 (2013).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetails Vol. 16, No. 17 Follow us on social media for the latest updates Metrics Downloaded 45 times History Received 13 March 2021 Accepted 29 March 2021 Published online 18 June 2021 Published in print July 2021 Information© 2021 Future Medicine LtdKeywordsendocytosismononuclear phagocytic systemnanomedicineprotein coronatumor penetrationAuthor contributionsL Liu: substantial contribution to the conception or design of the work; or the acquisition, analysis or interpretation of data for the work; and drafting the work or revising it critically for important intellectual content; H Dou: final approval of the version to be published; and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.Financial & competing interests disclosureThe authors wish to gratefully acknowledge financial support from the National Natural Science Foundation of China (21871180), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (SHDP201802), the ‘Shuguang Program’ supported by the Shanghai Municipal Education Commission (17SG12), the Science and Technology Commission of Shanghai Municipality (18520710300 and 17ZR1404100) and Biomedical Interdisciplinary Research Foundation of SJTU (YG2019QNB34). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download